Cargando…
Raised cardiovascular disease mortality after central nervous system tumor diagnosis: analysis of 171,926 patients from UK and USA
BACKGROUND: Patients with central nervous system (CNS) tumors may be at risk of dying from cardiovascular disease (CVD). We examined CVD mortality risk in patients with different histological subtypes of CNS tumors. METHODS: We analyzed UK(Wales)-based Secure Anonymized Information Linkage (SAIL) fo...
Autores principales: | Jin, Kai, Brennan, Paul M, Poon, Michael T C, Sudlow, Cathie L M, Figueroa, Jonine D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500688/ https://www.ncbi.nlm.nih.gov/pubmed/34647025 http://dx.doi.org/10.1093/noajnl/vdab136 |
Ejemplares similares
-
Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma
por: Fujimoto, Kenji, et al.
Publicado: (2020) -
Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults
por: Ji, Jianling, et al.
Publicado: (2021) -
Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
por: Batara, Julette Marie F, et al.
Publicado: (2022) -
Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients’ relatives
por: Alanen, Eljas, et al.
Publicado: (2023) -
Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors
por: Ho, Vincent K Y, et al.
Publicado: (2022)